Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
D-domain (square binding site)
[{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdb5/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdb5/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdb4/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdb4/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdb3/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdb3/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdb2/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdb2/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdb1/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdb1/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdb0/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdb0/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdaf/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdaf/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdae/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdae/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdad/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdad/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdac/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdac/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdab/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdab/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cdaa/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cdaa/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cda9/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cda9/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cda8/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cda8/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cda7/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cda7/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cda6/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cda6/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cda5/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cda5/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cda4/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cda4/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cda3/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cda3/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cda2/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cda2/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cda1/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cda1/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cda0/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cda0/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cd9f/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cd9f/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cd9e/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cd9e/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cd9d/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cd9d/63dd2a6e52f9f70020b4cd9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63dd2aa952f9f70020b4cd9c/63dd2a6e52f9f70020b4cd9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63dd2aa952f9f70020b4cd9c/63dd2a6e52f9f70020b4cd9b.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
D-domain,d domain,binding site,generic protein,Arcellx,ddCAR,ARC-SparX,sparx,protein,domain,binding domain,antigen binding,antigen receptor,recognition,CAR-T cell therapy,chimeric antigen receptor,synthetic,binding agent,synthetic binding agent,biotechnology,target-binding domain,cell therapy,immunotherapy,immune therapy,cancer treatment,cancer research,oncology,target specificity,binding affinity,active site,space-filled protein,space-filling,molecule,generic molecule,macromolecule,square
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
